New painkiller could ease chest tube placement
NCT ID NCT05044468
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two numbing medicines, EXPAREL and lidocaine, in 80 people with lung cancer who need a procedure called pleuroscopy. The goal is to see which one provides better pain relief after the procedure. Participants will receive one of the two drugs and report their chest pain levels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Liposomal bupivacaine (EXPAREL) and lidocaine
- What this could lead to
- If it works, this could provide better pain control for patients undergoing a lung procedure, making recovery more comfortable.
- What could go wrong
- This is a small, early-phase trial with only 80 participants, so results may not apply to everyone. There is also a risk of allergic reactions or the drug not working as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT PLEURAL NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.